You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Concord Drugs Ltd"

Concord Drugs Ltd Related Party Disclosure Under Regulation 23(9) Of SEBI(LODR) Regulation 2015

  • 14/06/2022
  • |
  • bse

Concord Drugs Ltd Announcement under Regulation 30 (LODR)-Resignation of Director

  • 02/06/2022
  • |
  • bse

Concord Drugs Ltd Audited Financial Results For Quarter And Financial Year Ended 31St March 2022.

  • 30/05/2022
  • |
  • bse

Concord Drugs Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 30/05/2022
  • |
  • bse

Concord Drugs Ltd Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2022

  • 17/05/2022
  • |
  • bse

Concord Drugs Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

  • 06/05/2022
  • |
  • bse

Concord Drugs Ltd Board Meeting Outcome for Resignation Of CS

  • 06/05/2022
  • |
  • bse

Concord Drugs Ltd Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulatio

  • 16/04/2022
  • |
  • bse

Concord Drugs Ltd Compliance Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation

  • 16/04/2022
  • |
  • bse

Concord Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 16/04/2022
  • |
  • bse

Concord Drugs Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 16/04/2022
  • |
  • bse

Concord Drugs Ltd Closure of Trading Window

  • 28/03/2022
  • |
  • bse

Concord Drugs Ltd Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 31.12.2021

  • 14/02/2022
  • |
  • bse

Concord Drugs Ltd Unaudited Financial Results For The Quarter Ended 31.12.2021

  • 14/02/2022
  • |
  • bse

Concord Drugs Ltd Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2021.

  • 28/01/2022
  • |
  • bse

Concord Drugs Ltd Shareholding for the Period Ended December 31 2021

  • 19/01/2022
  • |
  • bse

Concord Drugs Ltd Statement Of Investor Complaints For The Quarter Ended December 2021

  • 13/01/2022
  • |
  • bse

Concord Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 13/01/2022
  • |
  • bse

Concord Drugs Ltd Closure of Trading Window

  • 30/12/2021
  • |
  • bse

Concord Drugs Ltd Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011

  • 17/11/2021
  • |
  • bse
.